Skip to content
10-Q

Quarterly Report

Vera Therapeutics, Inc. VERA

0000950170-25-103022

← back to feed
Filed
Aug 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 30, 2025 63.82M sh
Shares Diluted Q2 2025 · Jun 30, 2025 63.79M sh
Shares Diluted Q2 2025 · Jun 30, 2025 63.73M sh
Shares Diluted Q2 2025 · Jun 30, 2024 54.73M sh
Shares Diluted Q2 2025 · Jun 30, 2024 52.85M sh
Capex Q2 2025 · Jun 30, 2025 $395K
Capex Q2 2025 · Jun 30, 2024 $89K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$109.2M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$58.61M
Long Term Debt Q2 2025 · Jun 30, 2025 $74.46M
Long Term Debt Q2 2025 · Dec 31, 2024 $50.69M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $49.12M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $92.65M
Stockholders Equity Q2 2025 · Jun 30, 2025 $468.28M
Stockholders Equity Q2 2025 · Mar 31, 2025 $535M
Stockholders Equity Q2 2025 · Dec 31, 2024 $577.16M
Stockholders Equity Q2 2025 · Jun 30, 2024 $327.87M
Stockholders Equity Q2 2025 · Mar 31, 2024 $353.54M
Stockholders Equity Q2 2025 · Dec 31, 2023 $101.69M
Current Liabilities Q2 2025 · Jun 30, 2025 $33.55M
Current Liabilities Q2 2025 · Dec 31, 2024 $25.37M
Total Liabilities Q2 2025 · Jun 30, 2025 $110.25M
Total Liabilities Q2 2025 · Dec 31, 2024 $78.53M
Current Assets Q2 2025 · Jun 30, 2025 $571.35M
Current Assets Q2 2025 · Dec 31, 2024 $651.22M
Total Assets Q2 2025 · Jun 30, 2025 $578.53M
Total Assets Q2 2025 · Dec 31, 2024 $655.68M
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.20
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.01
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.62
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.17
Eps Basic Q2 2025 · Jun 30, 2025 −$1.20
Eps Basic Q2 2025 · Jun 30, 2025 −$2.01
Eps Basic Q2 2025 · Jun 30, 2024 −$0.62
Eps Basic Q2 2025 · Jun 30, 2024 −$1.17
Sga Expense Q2 2025 · Jun 30, 2025 $21.95M
Sga Expense Q2 2025 · Jun 30, 2025 $37.86M
Sga Expense Q2 2025 · Jun 30, 2024 $8.03M
Sga Expense Q2 2025 · Jun 30, 2024 $15.94M
Rd Expense Q2 2025 · Jun 30, 2025 $58.2M
Rd Expense Q2 2025 · Jun 30, 2025 $99.47M
Rd Expense Q2 2025 · Jun 30, 2024 $29.31M
Rd Expense Q2 2025 · Jun 30, 2024 $52.51M
Net Income Q2 2025 · Jun 30, 2025 −$76.53M
Net Income Q2 2025 · Jun 30, 2025 −$128.23M
Net Income Q2 2025 · Mar 31, 2025 −$51.69M
Net Income Q2 2025 · Jun 30, 2024 −$33.71M
Net Income Q2 2025 · Jun 30, 2024 −$62.09M
Net Income Q2 2025 · Mar 31, 2024 −$28.38M
Operating Income Q2 2025 · Jun 30, 2025 −$80.14M
Operating Income Q2 2025 · Jun 30, 2025 −$137.34M
Operating Income Q2 2025 · Jun 30, 2024 −$37.34M
Operating Income Q2 2025 · Jun 30, 2024 −$68.46M